Predictive Factors for Local Recurrence after Intraoperative Microwave Ablation for Colorectal Liver Metastases

Simple Summary The European Society of Medical Oncology and National Comprehensive Cancer Network guidelines indicate that ablation is recommended as a stand-alone treatment or in combination with resection for colorectal liver metastases (CRLM) as long as all visible tumors are eradicated. However, local recurrence (LR) is a major setback for microwave ablation (MWA). Even though several LR predictors have been reported, those following intraoperative MWA still remain unclear. Therefore, we retrospectively analyzed CRLM cases to determine LR predictive factors following intraoperative MWA. The minimal ablation margins were measured using anatomic landmarks, and a multivariate analysis for LR predictors after intraoperative MWA revealed that the ablation margin was the most powerful predictor per patient and lesion. In addition, anatomical location (i.e., the posterosuperior segment defined as segments 1, 7, and 8), tumor size >15 mm, tumor size > 20 mm, and proximity to Glisson were the independent LR predictors per lesion. Abstract This study aimed to clarify local recurrence (LR) predictive factors following intraoperative microwave ablation (MWA) for colorectal liver metastases. The data from 195 patients with 1392 CRLM lesions, who were preoperatively diagnosed by gadolinium-enhanced MRI with diffusion-weighted imaging and dynamic CT and treated with intraoperative MWA (2450 MHz) with or without hepatectomy, from January 2005 to December 2019, were retrospectively reviewed and analyzed using logistic regression. In addition, the margins were measured on contrast-enhanced CT 6 weeks post-ablation. Overall, 1066 lesions were ablated. The LRs occurred in 44 lesions (4.1%) among 39 patients (20.0%). The multivariate analysis per patient showed that tumor size > 20 mm and ablation margin < 5 mm were significant predictors for LR. Furthermore, multivariate analysis per lesion revealed that segments 1, 7, and 8 and tumor size > 15 mm, ablation margin < 5 mm, tumor size > 20 mm, and proximity to the Glisson were significant LR predictors. Finally, the outcome of this study may help determine indications for MWA.

[1]  E. Ziv,et al.  3D margin assessment predicts local tumor progression after ablation of colorectal cancer liver metastases , 2022, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[2]  M. Donati,et al.  Potential for cure and predictors of long-term survival after radiofrequency ablation for colorectal liver metastases: A 20-years single-center experience. , 2022, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[3]  B. Lissenberg-Witte,et al.  Improved Outcomes of Thermal Ablation for Colorectal Liver Metastases: A 10-Year Analysis from the Prospective Amsterdam CORE Registry (AmCORE) , 2022, CardioVascular and Interventional Radiology.

[4]  E. Ziv,et al.  Biopsy and Margins Optimize Outcomes after Thermal Ablation of Colorectal Liver Metastases , 2022, Cancers.

[5]  A. Gangi,et al.  Consensus Guidelines for the Definition of Time-to-Event End Points in Image-guided Tumor Ablation: Results of the SIO and DATECAN Initiative , 2021, Radiology.

[6]  B. Lissenberg-Witte,et al.  Primary Tumor Sidedness, RAS and BRAF Mutations and MSI Status as Prognostic Factors in Patients with Colorectal Liver Metastases Treated with Surgery and Thermal Ablation: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE) , 2021, Biomedicines.

[7]  N. de’Angelis,et al.  Recurrence and survival following microwave, radiofrequency ablation, and hepatic resection of colorectal liver metastases: A systematic review and network meta-analysis. , 2021, Hepatobiliary & pancreatic diseases international : HBPD INT.

[8]  H. Van Vlierberghe,et al.  Local control of hepatocellular carcinoma and colorectal liver metastases after surgical microwave ablation without concomitant hepatectomy , 2021, Langenbeck's Archives of Surgery.

[9]  F. Orsi,et al.  Optimizing Loco Regional Management of Oligometastatic Colorectal Cancer: Technical Aspects and Biomarkers, Two Sides of the Same Coin , 2021, Cancers.

[10]  J. Meyerhardt,et al.  Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. , 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

[11]  Hongjie Fan,et al.  Periprocedural risk factors for incomplete radiofrequency ablation of liver metastases from colorectal cancer: a single-center retrospective analysis , 2021, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[12]  S. Hunt,et al.  Augmented reality improves procedural efficiency and reduces radiation dose for CT-guided lesion targeting: a phantom study using HoloLens 2 , 2020, Scientific Reports.

[13]  E. Ziv,et al.  Factors Associated With Local Tumor Control and Complications After Thermal Ablation of Colorectal Cancer Liver Metastases: A 15-year Retrospective Cohort Study. , 2020, Clinical colorectal cancer.

[14]  F. Gleeson,et al.  Factors predicting ablation site recurrence following percutaneous microwave ablation of colorectal hepatic metastases. , 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[15]  Meijin Huang,et al.  The local efficacy and influencing factors of ultrasound-guided percutaneous microwave ablation in colorectal liver metastases: a review of a 4-year experience at a single center , 2018, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[16]  D. Richel,et al.  Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis , 2018, CardioVascular and Interventional Radiology.

[17]  S. Silverman,et al.  Intraprocedural Ablation Margin Assessment by Using Ammonia Perfusion PET during FDG PET/CT-guided Liver Tumor Ablation: A Pilot Study. , 2018, Radiology.

[18]  M. Gonen,et al.  Percutaneous Microwave versus Radiofrequency Ablation of Colorectal Liver Metastases: Ablation with Clear Margins (A0) Provides the Best Local Tumor Control. , 2017, Journal of vascular and interventional radiology : JVIR.

[19]  E. Berber,et al.  Local recurrence after microwave thermosphere ablation of malignant liver tumors: results of a surgical series , 2017, Surgery.

[20]  K. Ahrar,et al.  Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status , 2017, The British journal of surgery.

[21]  Koray Karabulut,et al.  Local recurrence after laparoscopic radiofrequency ablation of malignant liver tumors: Results of a contemporary series , 2017, Journal of surgical oncology.

[22]  J. Ledermann,et al.  Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial , 2017, Journal of the National Cancer Institute.

[23]  J Ricke,et al.  ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  M. Gonen,et al.  Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center. , 2016, Radiology.

[25]  Ahmedin Jemal,et al.  Global patterns and trends in colorectal cancer incidence and mortality , 2016, Gut.

[26]  M. Bloomston,et al.  Microwave Ablation for Hepatic Malignancies: A Multiinstitutional Analysis , 2014, Annals of surgery.

[27]  J. Ledermann,et al.  Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983. , 2014, European journal of cancer.

[28]  Yi Li,et al.  Efficacy and safety of thermal ablation in patients with liver metastases , 2013, European journal of gastroenterology & hepatology.

[29]  Karen T. Brown,et al.  Margin Size is an Independent Predictor of Local Tumor Progression After Ablation of Colon Cancer Liver Metastases , 2013, CardioVascular and Interventional Radiology.

[30]  M. D'Angelica,et al.  Patterns of Recurrence After Ablation of Colorectal Cancer Liver Metastases , 2012, Annals of Surgical Oncology.

[31]  Yuman Fong,et al.  American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  David M. Mahvi,et al.  Hepatic Microwave Ablation With Multiple Antennae Results in Synergistically Larger Zones of Coagulation Necrosis , 2003, Annals of Surgical Oncology.

[33]  R. Doci,et al.  Patterns of Failure Following Surgical Resection of Colorectal Cancer Liver Metastases: Rationale for a Multimodal Approach , 1987, Annals of surgery.